The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s disease, lupus and rheumatoid arthritis.
Invitrogen has formed a collaboration to supply reagents for
Solexa's Genome Analysis System, a sequencing technology that has
the potential to generate over a billion bases of DNA sequence data
According to a recent report, analytic separation technology will
continue to evolve as limitations are addressed and standards grow
even more rigorous, as market drivers such as quality control,
instrument design, and software in...
According to a report, it takes 7-10 years to develop and market a
drug with costs exceeding $800 million (€625 million). This
revelation is set to add to the pressure already facing
pharmaceutical and biotechnology companies which...
The first grants have been awarded in the ENCODE program,an
extension of the Human Genome Project which is hoping to develop an
encyclopedia of function for all the sequences in the human genetic
map. A $35m pilot project aimed at...
Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Researchers have now completed the sequencing of the human genome,
to an accuracy of 99.999 per cent, nearly three years after the
first 'working' draft was published to great fanfare in June 2000.
The achievement comes...